Abstract
The vast majority (>90 %) of complications related to left atrial appendage (LAA) closure are procedure-related, occurring within 7 days of the index procedure [1]. These complications attenuate the overall clinical benefit of this strategy for stroke prophylaxis in patients with non-valvular atrial fibrillation and highlight the importance of the safe execution of the procedure to maximize the overall clinical benefits of LAA occlusion in this patient cohort [2]. The current chapter will outline the major procedural complications of LAA closure and discuss their management. Although a large number of LAA occlusion devices have now been developed [3], the majority of the discussion will center around second generation devices for which there is reasonable registry or randomized trial data available (i.e., WATCHMAN, Boston Scientific, and Amplatzer Cardiac Plug (ACP), St Jude Medical).
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123(4):417–24.
Holmes Jr DR, Lakkireddy DR, Whitlock RP, Waksman R, Mack MJ. Left atrial appendage occlusion: opportunities and challenges. J Am Coll Cardiol. 2014;63(4):291–8.
Bergmann MW, Landmesser U. Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques. EuroIntervention. 2014;10(4):497–504.
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42.
Holmes Jr DR, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.
Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011;77(5):700–6.
Urena M, Rodes-Cabau J, Freixa X, Saw J, Webb JG, Freeman M, et al. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy. J Am Coll Cardiol. 2013;62(2):96–102.
Schroeter MR, Danner BC, Hunlich M, Schillinger W. Uncommon delayed and late complications after percutaneous left atrial appendage closure with Amplatzer((R)) Cardiac Plug. Clin Res Cardiol. 2014;103(4):285–90.
Bianchi G, Solinas M, Gasbarri T, Bevilacqua S, Tiwari KK, Berti S, et al. Pulmonary artery perforation by plug anchoring system after percutaneous closure of left appendage. Ann Thorac Surg. 2013;96(1):e3–5.
Hanazawa K, Brunelli M, Saenger J, Grosse A, Raffa S, Lauer B, et al. Close proximity between pulmonary artery and left atrial appendage leading to perforation of the artery, tamponade and death after appendage closure using cardiac plug device. Int J Cardiol. 2014;175(2):e35–6.
Meier B, Tarbine SG, Costantini CR. Percutaneous management of left atrial appendage perforation during device closure. Catheter Cardiovasc Interv. 2014;83(2):305–7.
Bajaj NS, Parashar A, Agarwal S, Sodhi N, Poddar KL, Garg A, et al. Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. JACC Cardiovasc Interv. 2014;7(3):296–304.
Aminian A, Chouchane I, Compagnie M, Decubber M, Lalmand J. Delayed and fatal embolization of a left atrial appendage closure device. Circ Cardiovasc Interv. 2014;7(4):628–30.
Gupta P, Szczeklik M, Selvaraj A, Lall KS. Emergency surgical retrieval of a migrated left atrial appendage occlusion device. J Card Surg. 2013;28(1):26–8.
Pisani P, Sandrelli L, Fabbrocini M, Tesler UF, Medici D. Left-atrial-appendage occluder migrates in an asymptomatic patient. Tex Heart Inst J. 2014;41(4):443–4.
Plicht B, Konorza TF, Kahlert P, Al-Rashid F, Kaelsch H, Janosi RA, et al. Risk factors for thrombus formation on the Amplatzer Cardiac Plug after left atrial appendage occlusion. JACC Cardiovasc Interv. 2013;6(6):606–13.
Fernandez-Rodriguez D, Vannini L, Martin-Yuste V, Brugaletta S, Robles R, Regueiro A, et al. Medical management of connector pin thrombosis with the Amplatzer cardiac plug left atrial closure device. World J Cardiol. 2013;5(10):391–3.
Freixa X, Chan JL, Tzikas A, Garceau P, Basmadjian A, Ibrahim R. The Amplatzer Cardiac Plug 2 for left atrial appendage occlusion: novel features and first-in-man experience. EuroIntervention. 2013;8(9):1094–8.
Viles-Gonzalez JF, Kar S, Douglas P, Dukkipati S, Feldman T, Horton R, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol. 2012;59(10):923–9.
Casserly IP. Vascular access and closure issues in structural heart disease interventions. In: Carroll JD, Webb JG, editors. Structural heart disease interventions. Philadelphia: Lippincott Williams & Wilkins; 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Casserly, I.P., Walsh, K., Saw, J. (2016). Procedural Complications and Management. In: Saw, J., Kar, S., Price, M. (eds) Left Atrial Appendage Closure. Contemporary Cardiology. Humana Press, Cham. https://doi.org/10.1007/978-3-319-16280-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-16280-5_18
Publisher Name: Humana Press, Cham
Print ISBN: 978-3-319-16279-9
Online ISBN: 978-3-319-16280-5
eBook Packages: MedicineMedicine (R0)